Matthew C Kapusta Decibel Therapeutics, Inc. (DBTX) insider trading activity

Matthew C Kapusta is Director of Decibel Therapeutics, Inc.. Currently has a direct ownership of 0 shares of DBTX, which is worth approximately $0. The most recent transaction as insider was on Sep 25, 2023, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Matthew C Kapusta Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Sep 25 2023	SELL Sale (or disposition) back to the issuer	-	10,000 Reduced 100.0%	0 Common Stock
Mar 19 2023	BUY Grant, award, or other acquisition	-	10,000 Added 50.0%	10,000 Common Stock

Also insider at

QURE

uniQure N.V. Healthcare

CEO, Managing Director

MCK